Marimed (MRMD) Other financing activities (2013 - 2023)

Marimed (MRMD) has reported Other financing activities for 9 consecutive years, with $74000.0 the latest figure, recorded in Q3 2023.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $74000.0 in Q3 2023; TTM through Dec 2024 was $74000.0, a 32.11% decrease from a year earlier, with the FY2023 full-year figure at $109000.0, up 990.0% from the prior year.
• Other financing activities was $74000.0 for Q3 2023 at Marimed, up from $35000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $586642.0 in Q2 2019 and troughed at -$1.0 in Q4 2019.
• A 4-year average of $81744.1 and a median of $23900.0 in 2019 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 629.19% in 2019, down 100.0% in 2019.
• Over 4 years, Other financing activities stood at -$1.0 in 2019, then surged by 3200100.0% to $32000.0 in 2021, then slumped by 90.62% to $3000.0 in 2022, then jumped by 2366.67% to $74000.0 in 2023.
• The last three Other financing activities figures came in at $74000.0 (Q3 2023), $35000.0 (Q2 2023), and $3000.0 (Q1 2022), per Business Quant data.